Last Update18 Oct 25Fair value Decreased 0.99%
Valmet Oyj’s analyst price target has been slightly lowered from €28.74 to €28.46. Analysts point to steady but modest revisions in growth and margin forecasts supporting the update.
Analyst Commentary
Recent updates from the analyst community reflect both optimism and caution regarding Valmet Oyj’s outlook, valuation, and prospects for execution.
Bullish Takeaways- Bullish analysts highlight the company’s favorable risk-reward profile following upgrades. This view is supported by its robust order intake and strong market positioning.
- There is an expectation for improved growth in core segments, which could lead to outperforming margin targets over the next fiscal year.
- Recent upgrades to a higher rating signal increased confidence in management’s ability to execute on efficiency and integration initiatives.
- The revised price target indicates market belief in the potential for capital appreciation as the company delivers on strategic projects.
- Bearish analysts caution that current valuation already reflects much of the anticipated earnings recovery, which leaves limited room for upside surprise.
- There are ongoing concerns about the pace of margin expansion, particularly if market conditions remain muted.
- Modest forecast revisions suggest some skepticism regarding the sustainability of recent growth momentum.
What's in the News
- Valmet Oyj will deliver a new energy-efficient evaporation line with advanced technology to Altri Biotek mill in Portugal as part of a EUR 75 million transformation project. This initiative aims to improve the mill's energy and water efficiency. (Client Announcement)
- The company has received an order to supply a sack and kraft paper machine, as well as automation and services, to Guangxi Jianhui Paper in China. The project is intended to enhance packaging production capabilities, with startup scheduled for the end of 2026. (Client Announcement)
- Valmet will deliver an IntelliTissue 1600 tissue machine to PT Suparma Tbk’s mill in Surabaya, Indonesia. The new production line will increase tissue capacity by 26,500 tons per year, with startup planned for 2026. (Client Announcement)
- Valmet has signed a multi-year, nationwide agreement with Petrobras in Brazil to supply spare parts and services for Neles valves and equipment. The agreement supports operational continuity in oil, gas, and power generation. (Client Announcement)
- The company reaffirmed earnings guidance for 2025 and projects net sales to remain at the previous year's level. (Corporate Guidance)
Valuation Changes
- Consensus Analyst Price Target has declined slightly from €28.74 to €28.46.
- The Discount Rate has risen marginally from 7.47 percent to 7.56 percent, indicating slightly higher perceived risk or return expectations.
- The Revenue Growth forecast has edged down from 4.03 percent to 4.00 percent.
- The Net Profit Margin is projected to improve slightly, increasing from 9.41 percent to 9.44 percent.
- The Future P/E ratio has decreased from 11.80x to 11.69x, reflecting a modest shift in valuation assumptions.
Key Takeaways
- Simplified structure, local accountability, and digitalization initiatives are set to improve margins, stability, and recurring high-margin service revenues.
- Strategic focus on circularity, sustainability, and automation positions Valmet for long-term growth and expanding high-margin order backlog.
- Weak demand and margin pressures, reliance on volatile capital orders, and costly restructuring threaten earnings stability and challenge the pursuit of profitable growth.
Catalysts
About Valmet Oyj- Develops and supplies process technologies, automation, and services for the pulp, paper, and energy industries in North America, South America, China, Europe, the Middle East, Africa, and the Asia Pacific.
- The implementation of Valmet's new operating model, which simplifies structure and fosters faster decision-making and local accountability, is expected to drive recurring annual cost savings of around €80 million by early 2026. This structural catalyst should directly lower SG&A and COGS, supporting margin expansion and improved earnings over time.
- Valmet's strategic focus on advancing circularity in Biomaterial Solutions, including winning carbon capture-ready bioenergy projects, positions the company to capitalize on increased regulatory and customer demand for sustainable and low-carbon industrial solutions. This is likely to drive longer-term order growth, expanding both revenue and backlog.
- Investments in digitalization, Industrial Internet, and data-driven services are allowing Valmet to leverage its large installed base for predictive maintenance, improved customer service, and enhanced commercial effectiveness. These initiatives are expected to grow high-margin, recurring service revenues, which should boost overall net margins and earnings stability.
- The Process Performance Solutions segment, particularly in Automation and Flow Control, continues to deliver strong organic growth and rising EBITA margins (targeting 20% by 2030). This suggests Valmet is well placed to benefit from the ongoing industrial shift toward automation and process optimization, supporting top-line and margin growth ambitions.
- Increasing service market share-targeting a rise from 21% to 25% by 2030 through embedded life cycle approaches and targeted investments-should drive growth in high-margin services within Biomaterial Solutions. This will produce a structurally better revenue mix, supporting higher EBITA margins and more resilient earnings.
Valmet Oyj Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?- Analysts are assuming Valmet Oyj's revenue will grow by 4.1% annually over the next 3 years.
- Analysts assume that profit margins will increase from 4.9% today to 9.4% in 3 years time.
- Analysts expect earnings to reach €557.7 million (and earnings per share of €2.55) by about September 2028, up from €255.0 million today.
- In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 12.0x on those 2028 earnings, down from 21.3x today. This future PE is lower than the current PE for the GB Machinery industry at 20.1x.
- Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 7.32%, as per the Simply Wall St company report.
Valmet Oyj Future Earnings Per Share Growth
Risks
What could happen that would invalidate this narrative?- Declining net sales in core segments, specifically in Services and Process Technologies, signal ongoing demand softness and lower volumes, which could persist given cyclical weakness and secular decline in certain pulp and paper markets; this directly threatens revenue growth and near
- to medium-term earnings.
- Persistent margin weakness in the Biomaterial Solutions and Services segment (10% EBITA vs. 14% target) raises questions about operational leverage and the company's ability to deliver targeted margin improvements, particularly as the profit mix shifts towards capital-intensive, lower-margin business; this could suppress overall net margins.
- The company's reliance on large, lumpy capital orders (e.g., Arauco project) introduces significant order book and revenue volatility-if industry CapEx cycles slow or large clients delay project timing, Valmet may face earnings instability and unpredictable cash flows.
- Slowing transactional Services and consumables sales-particularly in Europe amid muted mill utilization rates-may reflect longer-term structural decline in traditional pulp, board, and paper sectors, making it difficult to sustain recurring high-margin service revenues.
- High restructuring and strategy renewal costs (€61 million in Q2) and dependence on ambitious cost-saving programs (€80 million annually) and global supply chain optimizations (€100 million target) carry execution and realization risks; if synergies are delayed or cost inflation persists, expected net profit and margin improvement may not materialize.
Valuation
How have all the factors above been brought together to estimate a fair value?- The analysts have a consensus price target of €29.314 for Valmet Oyj based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €36.0, and the most bearish reporting a price target of just €18.0.
- In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be €5.9 billion, earnings will come to €557.7 million, and it would be trading on a PE ratio of 12.0x, assuming you use a discount rate of 7.3%.
- Given the current share price of €29.44, the analyst price target of €29.31 is 0.4% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
How well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.



